AHA Friday voiced support for several legislative proposals before the House Energy and Commerce Committee to address the opioid crisis. In a letter to committee leaders, AHA Executive Vice President Tom Nickels said the association supports proposals to amend the Medicaid Institutions for Mental Disease exclusion; cover IMD substance use disorder treatment for pregnant women up to 12 months after delivery; and establish demonstration projects to study alternative emergency pain management protocols and expand provider capacity. AHA also endorsed draft legislation that would add chronic pain evaluation and management to Medicare’s initial preventive physical examination for new beneficiaries. Other AHA-supported proposals include directing the Centers for Medicare & Medicaid Services to standardize electronic prior authorization, providing grants for prescriber education, requiring state Medicaid programs to integrate prescription drug monitoring program use into clinical workflows, and expanding access to telehealth for SUD treatment. The Energy and Commerce Committee has held hearings on dozens of opioid-related bills in its jurisdiction, many of which its Health Subcommittee is expected to mark up on April 25.  

Related News Articles

Perspective
Public
Abraham Lincoln, among those whose legacy we honor with Presidents Day next week, might have put it this way: Thirteen score and three days from now… …
Headline
The Senate Special Committee on Aging held a hearing Feb. 11 on issues impacting physician burnout. The AHA provided a statement for the hearing and urged…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 11 hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the…
Headline
Update: The Senate passed the measure by a vote of 71-29.The Senate Jan. 30 is expected to pass a government funding plan ahead of a midnight deadline. A…
Headline
The AHA Jan. 28 released its 2026 Advocacy Agenda, containing the association’s key priorities for Congress, the administration, regulatory agencies and courts…
Headline
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect…